Melanoma drug resistance 2018
UCLA Jonsson Comprehensive Cancer Center and Cancer Cell
The integrated their melanoma four-stage differentiation framework with high-throughput drug sensitivity databases created by robotic screens to identify drugs that target resistant melanomas.